Skip to main content

enVVeno Medical Corp

NVNO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001661053

In the last 90 days, enVVeno Medical Corp insiders filed 0 open-market purchases and 1 sale; 17 institutions reported holding it in 13F filings for Q2 2026, worth $953.6K in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding enVVeno Medical Corp changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of NVNO: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders3736−1
Shares5.09M5.97M+873.3K (+17.2%)
Value$20.3M$5.40M−$14.9M (−73.4%)

New holders (11)

Institutions that held enVVeno Medical Corp at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to NVNO in Q3 2025
InstitutionSharesValue% of portfolio
CM Management, LLC600,000$543.7K0.45%
Susquehanna International Group, LLP154,471$140.0K0.00%
HRT Financial LP55,135$49.0K0.00%
Marshall Wace, LLP39,883$36.3K0.00%
AQR Capital Management LLC22,832$20.7K0.00%
Two Sigma Securities, LLC14,111$12.8K0.00%
Gsa Capital Partners LLP13,420$12.0K0.00%
Simplex Trading, LLC13,751$12.0K0.00%
Wolverine Asset Management LLC1,768$1.60K0.00%
Group One Trading, L.P.202$1830.00%
Jones Financial Companies LLLP20$190.00%

Sold out (12)

Institutions that held enVVeno Medical Corp at the end of Q2 2025 and filed for Q3 2025 without it.